Leary A, Estevez-Garcia P, Sabatier R, Ray-Coquard I, et al. ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer. BMC Cancer 2024;24:876.
PMID: 39039449